Status:
UNKNOWN
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
Lead Sponsor:
Blueskin AS
Conditions:
Alopecia Areata
Vitiligo
Eligibility:
All Genders
18+ years
Brief Summary
The objective of the study is to explore various clinical and biochemical parameters and their potential associations with disease severity, activity, and prognosis in atopic dermatitis, psoriasis, al...
Eligibility Criteria
Inclusion Criteria:
- Adult subjects >18 years of age at screening.
- Previous diagnosis by a physician of atopic dermatitis, psoriasis, vitiligo, or alopecia areata.
- Visible lesions and willingness to photograph weekly using their smartphone
- Availability of a smartphone
Exclusion Criteria:
- Has any physical attributes or skin conditions that in the opinion of the investigator might interfere with the evaluation of lesions (i.e., pigmentation, tattoos, extensive scarring, excessive hair growth or acne)
- Has other clinically relevant illness that could interfere with healing of lesions (e.g. keloid scaring)
- Current or previous malignant disease, including malignant melanoma and basal cell carcinoma, within 5 years
- Some patients may have more than one of the four conditions. This is not an exclusion criterion per se but must be recorded.
Key Trial Info
Start Date :
December 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT06319781
Start Date
December 15 2023
End Date
May 1 2025
Last Update
March 20 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanos Clinic, Gandrup
Gandrup, Denmark, 9362
2
Sanos Clinic, Herlev
Herlev, Denmark, 2730
3
Sanos Clinic, Vejle
Vejle, Denmark, 7100